Latest News
Jess Cardin, PhD, associate professor and Deputy Chair of Neuroscience, was featured in "NeURoscience Perspectives", an interview series led by John Foxe, PhD, director of the Del Monte Institute for Neuroscience at the University of Rochester.
- March 06, 2024
Yale researchers Dibyadeep Datta, PhD, assistant professor of psychiatry, and Amy Arnsten, PhD, Albert E. Kent Professor of Neuroscience and professor of psychology, led a study that probed a blood biomarker for early-stage Alzheimer’s disease. The findings were published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
- February 26, 2024
A new study led by the newly recruited Yale Neuroscience assistant professor Aaron Kuan reveals how structure and function come together in brain circuits to support decision-making.
- February 07, 2024Source: Current Biology
Thirteen-lined ground squirrels hibernate for several months each winter without access to water. New work led by Maddy Junkins & Ni Feng in the Gracheva lab sheds light on the neurophysiological mechanisms involved in fluid retention during hibernation.
- January 24, 2024Source: YaleNews
A new study offers insights into how living organisms distribute the energy needed to support all functions of the body — which likely also influences behavior.
- January 19, 2024Source: YaleNews
Yale’s research cores enable scientists across campus to interact, collaborate, and develop new applications that advance the university’s scientific mission.
- January 09, 2024
Yale School of Medicine’s Department of Neuroscience has been busy. From cutting the ribbon at our new research hub to unearthing secrets of the brain, there was plenty to share and celebrate this year.
- December 19, 2023Source: YaleNews
During the dedication of 100 College St. this month, Yale celebrated research, people, and the power of connection.
- November 27, 2023
A collaborative study led by Yale researchers reports the many gene expression changes that develop over the course of a neurodegenerative disorder called spinocerebellar ataxia type 1, shedding light on its progression.
- November 03, 2023Source: YaleNews
An experimental drug can reduce the toxic changes in tau proteins known to damage neurons in brains with Alzheimer’s disease, researchers report.